What one share of Oncotelic Therapeutics holds
Oncotelic Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | $0.56 |
|---|---|
| Cash and investments | $0.00 |
| Debt | $0.00 |
| Book value | $0.58 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$0.12 | — | — | — | $0.36 |
| 2019 | — | −$0.11 | — | — | — | $0.20 |
| 2020 | $0.02 | −$0.11 | — | — | — | $0.13 |
| 2021 | — | −$0.03 | — | — | — | $0.02 |
| 2022 | — | $0.01 | — | — | — | $0.05 |
| 2023 | $0.00 | −$0.02 | — | — | — | $0.03 |
| 2024 | — | −$0.01 | — | — | — | $0.02 |
| 2025 | — | $0.59 | — | — | — | $0.59 |
Common questions about Oncotelic Therapeutics
How much does one share of Oncotelic Therapeutics earn?
Over the last 12 months, each share of Oncotelic Therapeutics earned $0.56 of profit.
Does Oncotelic Therapeutics pay a dividend?
Oncotelic Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Oncotelic Therapeutics’s book value per share?
Oncotelic Therapeutics’s book value is $0.58 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Oncotelic Therapeutics have?
Each share of Oncotelic Therapeutics has $0.00 of cash and investments and $0.00 of debt, as of June 30, 2026.
Has Oncotelic Therapeutics bought back shares?
Oncotelic Therapeutics’s share count rose about 6781% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.